Conceptio
›
Archive
›
NCBI PubMed Central
NCBI PubMed Central
open access
Symptom Response Dynamics for Personalised Therapy with Subcutaneous Infliximab in Crohn's Disease: Insights from the Randomised, Placebo-Controlled, Phase 3 LIBERTY-CD Trial.
Schreiber S et al.
NCBI PubMed Central · Papers · License: Open Access
Open Source ↗
Direct PDF ↓
machine learning systems
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record
· ID 247570
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.